Viewing Study NCT03824951

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-01-29 @ 2:20 PM
Study NCT ID: NCT03824951
Status: UNKNOWN
Last Update Posted: 2019-01-31
First Post: 2019-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma
Sponsor: Allife Medical Science and Technology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory B-Cell Lymphoma View
Keywords: